recommended ghk-cu dosage and Protocol: The 30-Day Cycle ghk-cu dosage recommendations Peptide Dosing

Early studies in obese individuals showed some reductions in body fat mass, but findings are not consistent across trials: In one clinical trial, AOD9604 did not demonstrate statistically significant weight loss compared to placebo, suggesting its fat-burning effects may be modest without lifestyle intervention (summary of trials)

(1) BPC-157 is also commonly known as pentadecapeptide due to the 15 amino acids it is comprised of

Retrieved from Halford, J.C

In the rabbit bone defect study, BPC-157 treatment produced complete bony continuity across the defect site within six weeks in treated animals, while all control animals remained unhealed